Gentle exercise with leg cuffs may offer a new path to rehab for COPD patients
NCT ID NCT05984823
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether low-intensity body weight exercises combined with blood flow restriction (BFR) are safe and acceptable for people with COPD. Participants perform simple moves like sit-to-stand and knee raises at home, wearing inflatable cuffs on their thighs. The study focuses on feasibility, not yet on whether the approach improves breathing or fitness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- home-based body weight exercise with blood flow restriction (BFR)
- What this could lead to
- If feasible, this approach could offer a safe, accessible exercise option for people with COPD who struggle with traditional high-intensity rehab.
- What could go wrong
- This is a small feasibility study, not designed to prove effectiveness. Risks include bruising, blood clots, or muscle damage from BFR.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
27 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or Female * Aged 40 years or above * Diagnosed with COPD as per GOLD criteria (Forced expiratory volume(FEV1)/forced vital capacity(FVC) \<0.7) * FEV1 ≤ 80% predicted * Medical Research Council (MRC) dyspnoea scale ≥2 * BMI \<= 35 * Willing and able to give informed consent for participation in the study. * Stable dose of current regular medication for at least 4 weeks prior to study entry. * Clinically acceptable ECG at enrolment. * Able (in the investigators opinion) and willing to comply with all study requirements. * Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study. Exclusion Criteria: * Unable to communicate sufficiently in English * Unable to give informed consent or comply with testing and training protocol for any reason. * Acute exacerbation in the preceding 4 weeks (would become eligible 4 weeks following recovery). * Unable to undertake exercise due to physical or psychological barriers. * Contraindication to exercise training (American College of Sports Medicine guidelines) * Any major or uncontrolled comorbidity that would impair the participant's ability to exercise or would mean exercise was unsafe (e.g., uncontrolled diabetes, hypertension BP\>160/100, muscle or joint injuries which would limit ability to exercise). * Any other significant disease, disorder, or medical condition which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study including (but not limited to): Any clotting disorder Any bleeding disorder (e.g., haemophilia) Recent (\<3 months) venous thromboembolism, vascular (artery or vein) surgery to the legs, skin graft to the legs, and or arteriovenous fistula in the legs. Had one or both legs immobilisation in the last 4 weeks (e.g., prolonged bed rest, or recent orthopaedic intervention) Taking any anticoagulant medication Significant peripheral neuropathy * Current or within the last 3 months (or maximum relevant wash out period, whichever is longer), participation in an investigational medicinal product (IMP) or device trial at the time of screening. * Current or within the last 6 months (or maximum relevant wash out period, whichever is longer), participation in pulmonary rehabilitation or in another research study involving exercise training. * Scheduled elective surgery or other procedures requiring general anaesthesia during the study. * Female participants who are pregnant, lactating, or planning pregnancy during the course of the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NIHR Leicester Biomedical Research Centre - Respiratory
Leicester, Leicestershire, LE39QP, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The role of volumetric High-Resolution computed tomography (HRCT) of the chest in the assessment of patients with stable chronic obstructive pulmonary disease (COPD)
- Can AI help nurses guide At-Risk seniors to better care and lower costs?
- Fine-Mist inhalers aim to reach deep lungs in COPD
- App alerts COPD patients when their inhalers may be out of date
- Virtual reality may help COPD patients breathe easier during exercise
- Can a new injection help COPD patients cut steroid use?